Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma

Wei Li, Jianchang Li, Yuchuan Wu, Fabio Rancati, Stefania Vallese, Luca Raveglia, Junjun Wu, Rajeev Hotchandani, Nathan Fuller, Kristina Cunningham, Paul Morgan, Susan Fish, Rustem Krykbaev, Xin Xu, Steve Tam, Samuel J. Goldman, William Abraham, Cara Williams, Joseph Sypek, Tarek S. Mansour

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

MMP-12 plays a significant role in airway inflammation and remodeling. Increased expression and production of MMP-12 have been observed in the lungs of asthmatic patients. Compound 27 was identified as a potent and selective MMP-12 inhibitor possessing good physicochemical properties. In pharmacological studies, the compound was orally efficacious in an MMP-12 induced ear-swelling inflammation model in the mouse with a good dose response. This compound also exhibited oral efficacy in a naturally Ascaris-sensitized sheep asthma model showing significant inhibition of the late phase response to allergen challenge. This compound has been considered for further development as a treatment therapy for asthma.

Original languageEnglish
Pages (from-to)5408-5419
Number of pages12
JournalJournal of Medicinal Chemistry
Volume52
Issue number17
DOIs
StatePublished - Sep 10 2009
Externally publishedYes

Fingerprint

Metalloproteases
Matrix Metalloproteinases
Asthma
Ascaris
Airway Remodeling
Otitis
Matrix Metalloproteinase Inhibitors
Allergens
Sheep
Therapeutics
Pharmacology
Inflammation
Lung

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma. / Li, Wei; Li, Jianchang; Wu, Yuchuan; Rancati, Fabio; Vallese, Stefania; Raveglia, Luca; Wu, Junjun; Hotchandani, Rajeev; Fuller, Nathan; Cunningham, Kristina; Morgan, Paul; Fish, Susan; Krykbaev, Rustem; Xu, Xin; Tam, Steve; Goldman, Samuel J.; Abraham, William; Williams, Cara; Sypek, Joseph; Mansour, Tarek S.

In: Journal of Medicinal Chemistry, Vol. 52, No. 17, 10.09.2009, p. 5408-5419.

Research output: Contribution to journalArticle

Li, W, Li, J, Wu, Y, Rancati, F, Vallese, S, Raveglia, L, Wu, J, Hotchandani, R, Fuller, N, Cunningham, K, Morgan, P, Fish, S, Krykbaev, R, Xu, X, Tam, S, Goldman, SJ, Abraham, W, Williams, C, Sypek, J & Mansour, TS 2009, 'Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma', Journal of Medicinal Chemistry, vol. 52, no. 17, pp. 5408-5419. https://doi.org/10.1021/jm900809r
Li, Wei ; Li, Jianchang ; Wu, Yuchuan ; Rancati, Fabio ; Vallese, Stefania ; Raveglia, Luca ; Wu, Junjun ; Hotchandani, Rajeev ; Fuller, Nathan ; Cunningham, Kristina ; Morgan, Paul ; Fish, Susan ; Krykbaev, Rustem ; Xu, Xin ; Tam, Steve ; Goldman, Samuel J. ; Abraham, William ; Williams, Cara ; Sypek, Joseph ; Mansour, Tarek S. / Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma. In: Journal of Medicinal Chemistry. 2009 ; Vol. 52, No. 17. pp. 5408-5419.
@article{7a2726a1f00648838d872d69f305de95,
title = "Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma",
abstract = "MMP-12 plays a significant role in airway inflammation and remodeling. Increased expression and production of MMP-12 have been observed in the lungs of asthmatic patients. Compound 27 was identified as a potent and selective MMP-12 inhibitor possessing good physicochemical properties. In pharmacological studies, the compound was orally efficacious in an MMP-12 induced ear-swelling inflammation model in the mouse with a good dose response. This compound also exhibited oral efficacy in a naturally Ascaris-sensitized sheep asthma model showing significant inhibition of the late phase response to allergen challenge. This compound has been considered for further development as a treatment therapy for asthma.",
author = "Wei Li and Jianchang Li and Yuchuan Wu and Fabio Rancati and Stefania Vallese and Luca Raveglia and Junjun Wu and Rajeev Hotchandani and Nathan Fuller and Kristina Cunningham and Paul Morgan and Susan Fish and Rustem Krykbaev and Xin Xu and Steve Tam and Goldman, {Samuel J.} and William Abraham and Cara Williams and Joseph Sypek and Mansour, {Tarek S.}",
year = "2009",
month = "9",
day = "10",
doi = "10.1021/jm900809r",
language = "English",
volume = "52",
pages = "5408--5419",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "17",

}

TY - JOUR

T1 - Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma

AU - Li, Wei

AU - Li, Jianchang

AU - Wu, Yuchuan

AU - Rancati, Fabio

AU - Vallese, Stefania

AU - Raveglia, Luca

AU - Wu, Junjun

AU - Hotchandani, Rajeev

AU - Fuller, Nathan

AU - Cunningham, Kristina

AU - Morgan, Paul

AU - Fish, Susan

AU - Krykbaev, Rustem

AU - Xu, Xin

AU - Tam, Steve

AU - Goldman, Samuel J.

AU - Abraham, William

AU - Williams, Cara

AU - Sypek, Joseph

AU - Mansour, Tarek S.

PY - 2009/9/10

Y1 - 2009/9/10

N2 - MMP-12 plays a significant role in airway inflammation and remodeling. Increased expression and production of MMP-12 have been observed in the lungs of asthmatic patients. Compound 27 was identified as a potent and selective MMP-12 inhibitor possessing good physicochemical properties. In pharmacological studies, the compound was orally efficacious in an MMP-12 induced ear-swelling inflammation model in the mouse with a good dose response. This compound also exhibited oral efficacy in a naturally Ascaris-sensitized sheep asthma model showing significant inhibition of the late phase response to allergen challenge. This compound has been considered for further development as a treatment therapy for asthma.

AB - MMP-12 plays a significant role in airway inflammation and remodeling. Increased expression and production of MMP-12 have been observed in the lungs of asthmatic patients. Compound 27 was identified as a potent and selective MMP-12 inhibitor possessing good physicochemical properties. In pharmacological studies, the compound was orally efficacious in an MMP-12 induced ear-swelling inflammation model in the mouse with a good dose response. This compound also exhibited oral efficacy in a naturally Ascaris-sensitized sheep asthma model showing significant inhibition of the late phase response to allergen challenge. This compound has been considered for further development as a treatment therapy for asthma.

UR - http://www.scopus.com/inward/record.url?scp=69949090721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69949090721&partnerID=8YFLogxK

U2 - 10.1021/jm900809r

DO - 10.1021/jm900809r

M3 - Article

C2 - 19725580

AN - SCOPUS:69949090721

VL - 52

SP - 5408

EP - 5419

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 17

ER -